Mervyn Maze: Difference between revisions
Revising Citations |
No edit summary |
||
| Line 1: | Line 1: | ||
Mervyn Maze, MD, MB ChB has been a Professor in the Departments of Anesthesia and Pain Medicine, Intensive Care at the [[University of California, San Francisco]]<ref>{{cite web|url=http://www.anesthesiology.uci.edu/psh2014_maze.shtml|website=University of California, San Fransisco|last1=Maze|first1=Mervyn|accessdate=2016}}</ref> since 1988. He has also served as Professor and Chair at [[Imperial College London]]. |
Mervyn Maze, MD, MB ChB has been a Professor in the Departments of Anesthesia and Pain Medicine, Intensive Care at the [[University of California, San Francisco]]<ref>{{cite web|url=http://www.anesthesiology.uci.edu/psh2014_maze.shtml|website=University of California, San Fransisco|last1=Maze|first1=Mervyn|accessdate=2016}}</ref> since 1988. He has also served as Professor and Chair at [[Imperial College London]]. |
||
Maze was born in Cape Town, South Africa where he earned his Bachelor of Medicine and Bachelor of Surgery from [[University of Cape Town]], South Africa. He is the creator of discoveries that has resulted in 16 patents including a series of discoveries linked [[Neuroprotection]]. Maze recently published a study relating to the effects of inhaled xenon on cerebral white matter damage in cardiac patients.<ref>{{cite journal|date=March 15, 2016|title=Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest|url=http://jama.jamanetwork.com/article.aspx?articleid=2503174|journal=JAMA|volume=315|issue=11|doi= |
Maze was born in Cape Town, South Africa where he earned his Bachelor of Medicine and Bachelor of Surgery from [[University of Cape Town]], South Africa. He is the creator of discoveries that has resulted in 16 patents including a series of discoveries linked [[Neuroprotection]]. Maze recently published a study relating to the effects of inhaled xenon on cerebral white matter damage in cardiac patients.<ref>{{cite journal|date=March 15, 2016|title=Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest|url=http://jama.jamanetwork.com/article.aspx?articleid=2503174|journal=JAMA|volume=315|issue=11|doi=10.1001/jama|last1=Maze|first1=Mervyn|accessdate=2016}}</ref> |
||
'''Awards & Honors''' |
'''Awards & Honors''' |
||
Revision as of 03:38, 16 June 2016
Mervyn Maze, MD, MB ChB has been a Professor in the Departments of Anesthesia and Pain Medicine, Intensive Care at the University of California, San Francisco[1] since 1988. He has also served as Professor and Chair at Imperial College London.
Maze was born in Cape Town, South Africa where he earned his Bachelor of Medicine and Bachelor of Surgery from University of Cape Town, South Africa. He is the creator of discoveries that has resulted in 16 patents including a series of discoveries linked Neuroprotection. Maze recently published a study relating to the effects of inhaled xenon on cerebral white matter damage in cardiac patients.[2]
Awards & Honors
Maze was awarded the Excellence in Research Award from the American Society of Anesthesiology in 2003. He has also been awarded an Honorary Lifetime Membership in Israel Society of Anesthesiologists for contributions to Anesthesiology in Israel, 2012
References
- ^ Maze, Mervyn. University of California, San Fransisco http://www.anesthesiology.uci.edu/psh2014_maze.shtml. Retrieved 2016.
{{cite web}}: Check date values in:|accessdate=(help); Missing or empty|title=(help) - ^ Maze, Mervyn (March 15, 2016). "Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest". JAMA. 315 (11). doi:10.1001/jama. Retrieved 2016.
{{cite journal}}: Check date values in:|accessdate=(help)